Intermittent milrinone effect on long-term hemodynamic profile in patients with severe congestive heart failure

American Heart Journal

Volumn 138, Issue 2 I, 1999, Pages 241-246

  Hatzizacharias, A ^a   Makris, T ^a   Krespi, P ^a   Triposkiadis, F ^a   Voyatzi, P ^a   Dallanis, N ^a   Kyriakidis, M ^a  

^a NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

MILRINONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTINUOUS INFUSION; DRUG EFFICACY; FEMALE; FOLLOW UP; HEMODYNAMIC MONITORING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; MALE; PRIORITY JOURNAL;

EID: 0032799994     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70107-9     Document Type: Article

References (22)

1. Ho KL, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 1993;22:6A-13A.
2. Bourrassa MG, Gurne O, Bangdiwala SI, et al. Natural history and patterns of current practice in heart failure. J Am Coll Cardiol 1993; 22:14A-9A.
3. Adawia AA, Stankus GP, Stuart JC, et al. Characterisation of the effects on milrinone, a new and potent cardiac bipyridine, on isolated tissues from several animal species. J Cardiovasc Pharmacol 1983;5:804-11.
4. Jaski AE, Fifer MA, Wright RF, et al. Positive inotropic and vasodilator actions of milrinone on patients with severe congestive heart failure. J Clin Invest 1985;85:643-9.
5. Monrad ES, McKay RG, Balm DS, et al. Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone. Circulation 1984;70:1030-7.
6. Sherry KM, Locke TJ. Use of milrinone in cardiac surgical patients. Cardiovasc Drugs Ther 1993;7:671-5.
7. Anderson JL, Balm DS, Fein SA, et al. Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study. J Am Coll Cardiol 1987;9:711-22.
8. Anderson JL. Hemodynamic and clinical benefits with intravenous milrinone in severe chronic heart failure: results of a multicenter study in the United States. Am Heart J 1991;121:1956-64.
9. Pflugfelder PW, O'Neill BBJ, Ogilvie RI, et al. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure. Can J Cardiol 1991;7:5-10.
10. Simonton C, Chatterjee K, Cody R. Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation. J Am Coll Cardiol 1985;6:453-9.
11. Packer M, Carver J, Rodeheffer R, et al. Effect of oral milrinone on mortality in severe congestive heart failure. N Engl J Med 1991; 325:1468-75.
12. Marius-Nunez AI, Heaney L, Fernandez RN, et al. Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure. Am Heart J 1996; 805-8.
13. Forgosh L. Outpatient inotropic infusions and the impact on quality of life in patients with advanced heart failure. Cardiovasc Rev Rep 1997;18:11-22.
14. Feldman MD, Copelas L, Gwathmey JK. Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation 1987;75:331.
15. Jaski BE, Fifer MA, Wright RF, et al. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure; dose-response relationships and comparison to nitroprusside. J Clin Invest 1985;75:643.
16. Monrad ES, McKay RG, Baim DS. Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone. Circulation 1984;70:1030-7.
17. Guidelines for the evaluation and management of heart failure. J Am Coll Cardiol 1995;26:1376-98.
18. Likoff MJ, Weber KT, Andrews V, et al. Milrinone in the treatment of chronic cardiac failure: a controlled trial. Am Heart J 1985;110:135-42.
19. Konstam MA, Cody R. Short-term use of intravenous milrinone for heart failure. Am J Cardiol 1995;75:822-6.
20. Meiler SE, Leier CV. Effects of beta-adrenergic stimulation on skeletal muscle conditioning. Heart Failure 1986;2:128-37.
21. Unrerferth DV, Leier CV, Magorien RD, et al. Improvement of human myocardial mitochondria after dobutamine: a quantitative ultrastructural study. J Pharmacol Exp Ther 1980;215:527-32.
22. Anderson JL, Askins JC, Gilbert EM, et al. Occurrence of ventricular arrhythmias in patients receiving acute and chronic infusions of milrinone. Am Heart J 1986;111:466-74.